MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21873/invivo.14227

Медицинская библиотека · In vivo (Athens, Greece) · 2026

Effects of a Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin on Pancreas in Obese Diabetic Mice.

Sekikawa Ryoko, Uehara Hikari, Uno Kinuko, Sasase Tomohiko, Nakata Yusuke, Mori Yukina, Shinohara Masami, Sugimoto Miki, Ohta Takeshi

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND/AIM: Insulin secretion deficiency is one of the factors that cause onset and progression of type 2 diabetes, and pancreatic β-cell mass is also reduced in patients with type 2 diabetes. Some anti-diabetic drugs act directly on the pancreas to promote insulin secretion. Although such drugs provide good glycemic control, there are concerns regarding secondary failure during long-term treatment. Therefore, we aimed to investigate the effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, which does not act directly on the pancreas, using obese type 2 diabetic mice.

MATERIALS AND

METHODS

Six-week-old db/db mice were administered dapagliflozin at doses equivalent to 0.3 or 1 mg/kg in their diet for nine weeks.

RESULTS

Dapagliflozin treatment increased blood insulin levels and improved hyperglycemia. Histological analysis showed an increase in islet areas and improved islet irregularity and fibrosis in a dose-dependent manner. Immunostaining also showed a dose-dependent increase in β-cell positive areas and decrease in the ratio of α-cell positive area/β-cell positive area. Furthermore, dapagliflozin treatment suppressed the expression of CD44 (an inflammation- and fibrosis-related factor) around the pancreatic islets.

CONCLUSION

Treatment with dapagliflozin for nine weeks increases insulin secretion and preserves β-cell areas in type 2 diabetic mice, suggesting that long-term administration of dapagliflozin may have a protective effect on pancreas affected by diabetes.

Для цитирования: Sekikawa Ryoko, Uehara Hikari, Uno Kinuko, Sasase Tomohiko, Nakata Yusuke, Mori Yukina, Shinohara Masami, Sugimoto Miki, Ohta Takeshi. Effects of a Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin on Pancreas in Obese Diabetic Mice.. In vivo (Athens, Greece). 2026. DOI: 10.21873/invivo.14227.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.